Developmental deviation in delay discounting as a transdiagnostic indicator of risk for child psychopathology.
ADHD
Delay discounting
development
household income
transdiagnostic
Journal
Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
accepted:
19
06
2023
pmc-release:
01
02
2025
medline:
17
1
2024
pubmed:
1
8
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
The tendency to prefer smaller, immediate rewards over larger, delayed rewards is known as delay discounting (DD). Developmental deviations in DD may be key in characterizing psychiatric and neurodevelopmental disorders. Recent work empirically supported DD as a transdiagnostic process in various psychiatric disorders. Yet, there is a lack of research relating developmental changes in DD from mid-childhood to adolescence to psychiatric and neurodevelopmental disorders. Additionally, examining the interplay between socioeconomic status/total household income (THI) and psychiatric symptoms is vital for a more comprehensive understanding of pediatric pathology and its complex relationship with DD. The current study addresses this gap in a robust psychiatric sample of 1843 children and adolescents aged 5-18 (M = 10.6, SD = 3.17; 1,219 males, 624 females). General additive models (GAMs) characterized the shape of age-related changes in monetary and food reward discounting for nine psychiatric disorders compared with neurotypical youth (NT; n = 123). Over 40% of our sample possessed a minimum of at least three psychiatric or neurodevelopmental disorders. We used bootstrap-enhanced Louvain community detection to map DD-related comorbidity patterns. We derived five subtypes based on diagnostic categories present in our sample. DD patterns were then compared across each of the subtypes. Further, we evaluated the effect of cognitive ability, emotional and behavioral problems, and THI in relation to DD across development. Higher discounting was found in six of the nine disorders we examined relative to NT. DD was consistently elevated across development for most disorders, except for depressive disorders, with age-specific DD differences compared with NTs. Community detection analyses revealed that one comorbidity subtype consisting primarily of Attention-Deficit/Hyperactivity Disorder (ADHD) Combined Presentation and anxiety disorders displayed the highest overall emotional/behavioral problems and greater DD for the food reward. An additional subtype composed mainly of ADHD, predominantly Inattentive Presentation, learning, and developmental disorders, showed the greatest DD for food and monetary rewards compared with the other subtypes. This subtype had deficits in reasoning ability, evidenced by low cognitive and academic achievement performance. For this ADHD-I and developmental disorders subtype, THI was related to DD across the age span such that participants with high THI showed no differences in DD compared with NTs. In contrast, participants with low THI showed significantly worse DD trajectories than all others. Our results also support prior work showing that DD follows nonlinear developmental patterns. We demonstrate preliminary evidence for DD as a transdiagnostic marker of psychiatric and neurodevelopmental disorders in children and adolescents. Comorbidity subtypes illuminate DD heterogeneity, facilitating the identification of high-risk individuals. Importantly, our findings revealed a marked link between DD and intellectual reasoning, with children from lower-income households exhibiting lower reasoning skills and heightened DD. These observations underscore the potential consequences of compromised self-regulation in economically disadvantaged individuals with these disorders, emphasizing the need for tailored interventions and further research to support improved outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The tendency to prefer smaller, immediate rewards over larger, delayed rewards is known as delay discounting (DD). Developmental deviations in DD may be key in characterizing psychiatric and neurodevelopmental disorders. Recent work empirically supported DD as a transdiagnostic process in various psychiatric disorders. Yet, there is a lack of research relating developmental changes in DD from mid-childhood to adolescence to psychiatric and neurodevelopmental disorders. Additionally, examining the interplay between socioeconomic status/total household income (THI) and psychiatric symptoms is vital for a more comprehensive understanding of pediatric pathology and its complex relationship with DD.
METHODS
METHODS
The current study addresses this gap in a robust psychiatric sample of 1843 children and adolescents aged 5-18 (M = 10.6, SD = 3.17; 1,219 males, 624 females). General additive models (GAMs) characterized the shape of age-related changes in monetary and food reward discounting for nine psychiatric disorders compared with neurotypical youth (NT; n = 123). Over 40% of our sample possessed a minimum of at least three psychiatric or neurodevelopmental disorders. We used bootstrap-enhanced Louvain community detection to map DD-related comorbidity patterns. We derived five subtypes based on diagnostic categories present in our sample. DD patterns were then compared across each of the subtypes. Further, we evaluated the effect of cognitive ability, emotional and behavioral problems, and THI in relation to DD across development.
RESULTS
RESULTS
Higher discounting was found in six of the nine disorders we examined relative to NT. DD was consistently elevated across development for most disorders, except for depressive disorders, with age-specific DD differences compared with NTs. Community detection analyses revealed that one comorbidity subtype consisting primarily of Attention-Deficit/Hyperactivity Disorder (ADHD) Combined Presentation and anxiety disorders displayed the highest overall emotional/behavioral problems and greater DD for the food reward. An additional subtype composed mainly of ADHD, predominantly Inattentive Presentation, learning, and developmental disorders, showed the greatest DD for food and monetary rewards compared with the other subtypes. This subtype had deficits in reasoning ability, evidenced by low cognitive and academic achievement performance. For this ADHD-I and developmental disorders subtype, THI was related to DD across the age span such that participants with high THI showed no differences in DD compared with NTs. In contrast, participants with low THI showed significantly worse DD trajectories than all others. Our results also support prior work showing that DD follows nonlinear developmental patterns.
CONCLUSIONS
CONCLUSIONS
We demonstrate preliminary evidence for DD as a transdiagnostic marker of psychiatric and neurodevelopmental disorders in children and adolescents. Comorbidity subtypes illuminate DD heterogeneity, facilitating the identification of high-risk individuals. Importantly, our findings revealed a marked link between DD and intellectual reasoning, with children from lower-income households exhibiting lower reasoning skills and heightened DD. These observations underscore the potential consequences of compromised self-regulation in economically disadvantaged individuals with these disorders, emphasizing the need for tailored interventions and further research to support improved outcomes.
Identifiants
pubmed: 37524685
doi: 10.1111/jcpp.13870
pmc: PMC10828118
mid: NIHMS1918612
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
148-164Subventions
Organisme : NICHD NIH HHS
ID : P50 HD103538
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH091864
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH099059
Pays : United States
Informations de copyright
© 2023 Association for Child and Adolescent Mental Health.
Références
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Psychiatry Res. 2019 Sep;279:15-22
pubmed: 31279246
Neurosci Biobehav Rev. 2021 Aug;127:689-708
pubmed: 34048858
Br J Psychiatry. 2007 Apr;190:293-8
pubmed: 17401034
J Child Psychol Psychiatry. 2006 Nov;47(11):1152-8
pubmed: 17076754
JAMA Psychiatry. 2023 Jan 1;80(1):95
pubmed: 36383398
Res Dev Disabil. 2013 Oct;34(10):3168-81
pubmed: 23886759
Psychol Med. 2021 Aug;51(11):1799-1806
pubmed: 34184631
Arch Gen Psychiatry. 2011 Apr;68(4):419-27
pubmed: 21464366
Child Neuropsychol. 2018 Nov;24(8):1026-1046
pubmed: 28768457
Front Psychol. 2018 Sep 03;9:1545
pubmed: 30233449
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jul;1(4):316-325
pubmed: 27722208
Trends Cogn Sci. 2012 Mar;16(3):174-80
pubmed: 22336729
J Abnorm Child Psychol. 2010 Oct;38(7):961-9
pubmed: 20467805
J Psychiatr Res. 2022 Mar;147:291-300
pubmed: 35123338
J Behav Ther Exp Psychiatry. 2010 Sep;41(3):258-64
pubmed: 20219184
Int J Methods Psychiatr Res. 2010 Sep;19(3):167-76
pubmed: 20812292
Neuroimage. 2020 Jul 1;214:116678
pubmed: 32119986
Br J Psychol. 2004 Aug;95(Pt 3):269-82
pubmed: 15296535
J Atten Disord. 2012 Apr;16(3):190-8
pubmed: 22290696
Psychol Med. 2014 Jul;44(9):1825-34
pubmed: 24176142
Health Aff (Millwood). 2008 Mar-Apr;27(2):393-403
pubmed: 18332495
Psychiatry Res Neuroimaging. 2017 Nov 30;269:97-105
pubmed: 28988149
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
Dev Cogn Neurosci. 2018 Nov;34:101-113
pubmed: 30121543
J Neural Transm (Vienna). 2008;115(2):221-6
pubmed: 17876680
Biol Psychiatry. 2014 Apr 15;75(8):653-9
pubmed: 24199665
Depress Anxiety. 2017 May;34(5):463-470
pubmed: 28009473
Aging Ment Health. 2009 Nov;13(6):818-26
pubmed: 19888702
Trends Cogn Sci. 2019 Jul;23(7):584-601
pubmed: 31153774
Neurosci Biobehav Rev. 2019 Aug;103:133-149
pubmed: 31220503
J Res Adolesc. 2015 Mar;25(1):36-43
pubmed: 25750491
PLoS One. 2014 Nov 05;9(11):e111739
pubmed: 25372136
J Exp Anal Behav. 2020 May;113(3):657-679
pubmed: 32147840
Dev Sci. 2012 Nov;15(6):791-800
pubmed: 23106733
Exp Clin Psychopharmacol. 2006 Aug;14(3):318-28
pubmed: 16893275
J Int Neuropsychol Soc. 2015 Sep;21(8):584-95
pubmed: 26416095
Psychol Med. 2023 Mar;53(4):1649-1657
pubmed: 35080193
Sci Rep. 2021 Apr 14;11(1):8139
pubmed: 33854103
Pediatrics. 2011 Mar;127(3):462-70
pubmed: 21300675
Biol Psychiatry. 2015 May 15;77(10):846-7
pubmed: 25925716
Sci Data. 2017 Dec 19;4:170181
pubmed: 29257126
J Atten Disord. 2021 Jan;25(2):171-187
pubmed: 29806533
Psychopharmacology (Berl). 2011 Aug;216(3):305-21
pubmed: 21373791
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Exp Clin Psychopharmacol. 2014 Jun;22(3):222-8
pubmed: 24708144
JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186
pubmed: 31461131
J Autism Dev Disord. 2013 Jul;43(7):1555-67
pubmed: 23179340
Dev Cogn Neurosci. 2019 Jun;37:100642
pubmed: 31004982
J Abnorm Psychol. 2011 Nov;120(4):911-21
pubmed: 21875166
Psychiatry Res. 2014 Aug 30;223(2):113-20
pubmed: 24929553
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Apr;7(4):352-361
pubmed: 33706021
Psychol Med. 2019 Jan;49(2):190-199
pubmed: 30070191
Prim Care Companion CNS Disord. 2014;16(3):
pubmed: 25317366
J Affect Disord. 2013 Jun;148(2-3):220-7
pubmed: 23267726
Health Econ. 2005 Dec;14(12):1197-215
pubmed: 15945040